1998 update on antiphospholipid antibodies

Current Opinion in Rheumatology

Volumn 10, Issue 5, 1998, Pages 426-430

  Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; HUMAN; HYPERCOAGULABILITY; PRIORITY JOURNAL; SHORT SURVEY; SPONTANEOUS ABORTION; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD COAGULATION DISORDERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATOLOGY; SEROEPIDEMIOLOGIC STUDIES;

EID: 0031719133     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199809000-00005     Document Type: Short Survey

References (53)

1. Oger E, Lernyer C, Dueymes M, Le Moigne E, Bressolette L, Escoffre M, Youinou P, Mottier D: Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus. Lupus 1997, 6:455-461.
2. Bazzan M, Tamponi G, Vaccarino A, Montaruli B, Aluffi E, Schinco P, Pannocchia A, Borchiellini A, Rabbia C, Pileri A: Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease. Haematologica 1997, 82:420-422.
3. Schattner A, Kasher I, Berrebi A: Causes and outcome of deep-vein thrombosis in otherwise-healthy patients under 50 years. Q J Med 1997, 90:283-287.
4. Verthelyi D, Ansar Ahmed S: Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun 1997, 10:115-125.
5. Abuaf N, Laperche S, Rajoely B, Carsique R, Deschamps A, Rouquette AM, Barthet C, Khaled Z, Marbot C, Saab N, et al.: Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 1997, 77:856-861.
6. Loizou S, Cazabon JK, Walport MJ, Tait D, So AK: Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997, 40:103-108.
7. Merrill JT, Shen C, Gugnani M, Lahita RG, Mongey AB: High prevalence of antiphospholipid antibodies in patients taking procainamide. J Rheumatol 1997, 24:1083-1088.
8. Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G: Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus: a meta-analysis. Lupus 1997, 6:467-473.
9. Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellmann D, Corash L: The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of 60 consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody. Ann Intern Med 1987, 106:524-531.
10. Antiphospholipid Antibodies and Stroke Study Group: Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death: the Antiphospholipid Antibodies and Stroke Study Group (APASS). Neurology 1997, 48:91-94.
11. Nojima J, Suehisa E, Akita N, Toku M, Fushimi R, Tada H, Kuratsune H, Machii T, Kitani T, Amino N: Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant. Br J Haematol 1997, 96:447-450.
12. Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN: A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis. Arch Intern Med 1997, 157:2101-2108.
13. Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL: IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death: a prospective cohort study. Stroke 1997, 28:1660-1665.
14. Lopez-Soto A, Cervera R, Font J, Bove A, Reverter JC, Munoz FJ, Miret C, Espinosa G, Ordinas A, Ingelmo M: Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol 1997, 15:143-149.
15. Molina JF, Gutierrez-Urena S, Molina J, Uribe O, Richards S, De Ceulaer C, Garcia C, Wilson WA, Gharavi AE, Espinoza LR: Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J Rheumatol 1997, 24:291-296.
16. Sammaritano LR, Ng S, Sobel R, Lo SK, Simantov R, Furie R, Kaell A, Silverstein R, Salmon JE: Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 1997, 40:1998-2006.
17. Panzer S, Pabinger I, Gschwandtner ME, Mayr WR, Hutter D: Lupus anticoagulants: strong association with the major histocompatibility complex class II and platelet antibodies. Br J Haematol 1997, 98:342-345.
18. Marie I, Levesque H, Heron F, Cailleux N, Borg JY, Courtois H: Acute adrenal failure secondary to bilateral infarction of the adrenal glands as the first manifestation of primary antiphospholipid antibody syndrome [letter]. Ann Rheum Dis 1997, 56:567-568.
19. Jennings I, Kitchen S, Woods TA, Preston FE, Greaves M: Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost 1997, 77:934-937.
20. McIntyre JA, Wagenknecht DR, Sugi T: Phospholipid binding plasma proteins required for antiphospholipid antibody detection: an overview. Am J Reprod Immunol 1997, 37:101-110.
21. Najmey SS, Keil LB, Adib DY, DeBari VA: The association of antibodies to beta 2 glycoprotein I with the antiphospholipid syndrome: a meta-analysis. Ann Clin Lab Sci 1997, 27:41-46.
22. Guerin J, Feighery C, Sim RB, Jackson J: Antibodies to beta2-glycoprotein I: a specific marker for the antiphospholipid syndrome. Clin Exp Immunol 1997, 109:304-309.
23. Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A: Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997, 24:1710-1715.
24. Alarcón-Segovia D, Mestanza M, Cabiedes J, Cabrai AR: The antiphospholipid/cofactor syndromes: II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. J Rheumatol 1997, 24:1545-1551.
25. Takeya H, Mon T, Gabazza EC, Kuroda K, Deguchi H, Matsuura E, Ichikawa K, Koike T, Suzuki K: Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. J Clin Invest 1997, 99:2260-2268.
26. Cote HC, Huntsman DG, Wu J, Wadsworth LD, MacGillivray RT: A new method for characterization and epitope determination of a lupus anticoagulant-associated neutralizing antiprothrombin antibody. Am J Clin Pathol 1997, 107:197-205.
27. Galli M, Beretta G, Daldossi M, Severs EM, Barbui T: Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997, 77:486-491.
28. Font J, Lopez-Soto A, Cervera R, Casals FJ, Reverter JC, Munoz FJ, Miret C, Bove A, Ordinas A, Ingelmo M: Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients. Thromb Res 1997, 86:37-48.
29. Cuadrado MJ, Lopez-Pedrera C, Khamashta MA, Camps MT, Tinahones F, Torres A, Hughes GR, Velasco F: Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997, 40:834-841.
30. Del Papa N, Raschi E, Catelli L, Khamashta MA, Ichikawa K, Tincani A, Balestrieri G, Meroni PL: Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies. Am J Reprod Immunol 1997, 38:212-217.
31. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, Koike T, Balestrieri G, Tincani A, Hughes GR, Meroni PL: Endothelial cells as target for antiphospholipid antibodies: human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997, 40:551-561.
32. Cockwell P, Tse WY, Savage CO: Activation of endothelial cells in thrombosis and vasculitis. Scand J Rheumatol 1997, 26:145-150.
33. Rand JH, Wu XX, Andree HAM, Lockwood CJ, Guller S, Scher J, Harpel PC: Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism. N Engl J Med 1997, 337:154-160. The authors define a potential mechanism of antiphospholipid-induced pregnancy losses.
34. Ferro D, Pittoni V, Quintarelli C, Basili S, Saliola M, Caroselli C, Valesini G, Violi F: Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. Circulation 1997, 95:1425-1432.
35. Zangari M, Lockwood CJ, Scher J, Rand JH: Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies. Thromb Res 1997, 85:177-183.
36. Vaarala O, Puurunen M, Lukka M, Altfkhan G, Leirisalo-Repo M, Aho K, Palosuo T: Affinity purified cardiolipin binding antibodies show heterogeneity in their binding to oxidized low density lipoprotein. Clin Exp Immunol 1996, 104:269-274.
37. Horkko S, Miller E, Dudl E, Rearen P, Curtiss LK, Zvaifler NJ, Terkeltaub R, et al.: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. J Clin Invest 1996, 98:815-825.
38. Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T: Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 1997, 107:569-573. A pivotal article on the connection between aPLs and atherosclerosis.
39. George J, Afek A, Gilburd B, Levy Y, Blank M, Kopolovic J, Harats D, Shoenfeld Y: Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997, 6:723-729.
40. Atsumi T, Khamashta MA, Andujar C, Leandro MJ, Amengual O, Ames PRJ, Hughes GRV: Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol 1998, 25:69-73.
41. Specker C, Rademacher J, Sohngen D, Sitzer M, Janda I, Siebler M, Steinmetz H, Schneider M: Cerebral microemboli in patients with antiphospholipid syndrome. Lupus 1997, 6:638-644. Transcranial Doppler ultrasonography may allow the identification of patients with aPLs who are at the greatest risk of stroke.
42. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA: The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997, 3:377-386.
43. Kent M, Alvarez F, Vogt E, Fyffe R, Ng AK, Rote N: Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 1997, 24:1725-1733.
44. Nesher G, Ilany J, Rosenmann D, Abraham AS: Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997, >27:27-35.
45. Agirbasli MA, Hansen DE, Byrd BFr: Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome. J Am Soc Echocardiogr 1997, 10:877-880.
46. Cowchock S, Reece EA: Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial. Am J Obstet Gynecol 1997, 176:1099-1100.
47. Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott RT Jr: Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil Steril 1997, 67:1084-1190.
48. Ruffatti A, Orsini A, Di Lenardo L, Nardelli GB, Patrassi GM, Truscia D, Brigato G, Grella P, Todesco S: A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. Clin Exp Rheumatol 1997, 15:499-505.
49. Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253-257.
50. Khamashta MA, Mackworth-Young C: Antiphospholipid (Hughes') syndrome [editorial]. BMJ 1997, 314:244.
51. al-Sayegh FA, Ensworth S, Huang S, Stein HB, Klinkhoff AV: Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome. J Rheumatol 1997, 24:1716-1718.
52. Julkunen H, Hedman C, Kauppi M: Thrombolysis for acute ischemic stroke in the primary antiphospholipid syndrome. J Rheumatol 1997, 24:181-183.
53. Neuwelt CM, Daikh Dl, Linfoot JA, Pfister DA, Young RG, Webb RL, London SS, Asherson RA: Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum 1997, 40:1534-1539.